14 employees
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
2011
$26M
from 2 investors over 2 rounds
AZTherapies, Inc. raised $26M on October 18, 2019
Investors: Spinnaker Capital LLC and Wexford Capital LP